◼ Archived
Business
🔮 fades ✓
FDA’s top gene therapy regulator is leaving his role
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
Kidney Disease
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Nearly 1 million bottles of heart and kidney medication recalled over foreign substance found on tablets
Nearly 1 million bottles of heart and kidney medication are being recalled due to a foreign substance found on tablets.